Nasus Pharma (NSRX) Shares Outstanding (Entity) (2024 - 2025)

Nasus Pharma (NSRX) Shares Outstanding (Entity) (2024 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Entity.) (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	2.41 Bn
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	1.77 Bn
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	2.47 Bn
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	1.90 Bn
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	1.55 Bn
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	540.60 Mn
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	1.24 Bn
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	5.70 Bn
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	-
10	Nasus Pharma	32.04 Mn	32.04 Mn	-	9.02 Mn

Download Data